[HTML] nature.comFull View

[HTML][HTML] Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up

S Bernaerts, B Boets, J Steyaert, N Wenderoth… - Translational …, 2020 - nature.com
Intranasal administration of the neuropeptide oxytocin (IN-OT) is increasingly considered as
a potential treatment for targeting the core symptoms of autism spectrum disorder (ASD), but …
被引用次数：29 相关文章

Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up

B Sylvie, B Bart, J Steyaert… - Translational …, 2020 - search.proquest.com
Intranasal administration of the neuropeptide oxytocin (IN-OT) is increasingly considered as
a potential treatment for targeting the core symptoms of autism spectrum disorder (ASD), but …

Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up

S Bernaerts, B Boets, J Steyaert… - Translational …, 2020 - research-collection.ethz.ch
Intranasal administration of the neuropeptide oxytocin (IN-OT) is increasingly considered as
a potential treatment for targeting the core symptoms of autism spectrum disorder (ASD), but …

Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up.

S Bernaerts, B Boets, J Steyaert… - Translational …, 2020 - search.ebscohost.com
Intranasal administration of the neuropeptide oxytocin (IN-OT) is increasingly considered as
a potential treatment for targeting the core symptoms of autism spectrum disorder (ASD), but …
[HTML] nih.gov

[HTML][HTML] Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up

S Bernaerts, B Boets, J Steyaert… - Translational …, 2020 - ncbi.nlm.nih.gov
Intranasal administration of the neuropeptide oxytocin (IN-OT) is increasingly considered as
a potential treatment for targeting the core symptoms of autism spectrum disorder (ASD), but …

Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up

S Bernaerts, B Boets, J Steyaert, N Wenderoth… - 2020 - pubmed.ncbi.nlm.nih.gov
Intranasal administration of the neuropeptide oxytocin (IN-OT) is increasingly considered as
a potential treatment for targeting the core symptoms of autism spectrum disorder (ASD), but …

Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up.

S Bernaerts, B Boets, J Steyaert… - Translational …, 2020 - europepmc.org
Intranasal administration of the neuropeptide oxytocin (IN-OT) is increasingly considered as
a potential treatment for targeting the core symptoms of autism spectrum disorder (ASD), but …

[引用][C] Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up.

S Bernaerts, B Boets, J Steyaert, N Wenderoth… - Translational …, 2020 - sonar.ch
English Intranasal administration of the neuropeptide oxytocin (IN-OT) is increasingly
considered as a potential treatment for targeting the core symptoms of autism spectrum …

Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up.

S Bernaerts, B Boets, J Steyaert… - Translational …, 2020 - europepmc.org
Intranasal administration of the neuropeptide oxytocin (IN-OT) is increasingly considered as
a potential treatment for targeting the core symptoms of autism spectrum disorder (ASD), but …